Call for Action: Pre-Exposure Prophylaxis (PrEP) and the HIV/AIDS Epidemic in the United States

Around the world (including the United States), thousands of HIV-negative people are enrolled in clinical trials to determine whether taking anti-retroviral drugs could reduce the risk of being infected with HIV. This strategy is called pre-exposure prophylaxis, or PrEP.

By the middle of next year, more people will be enrolling in PrEP trials than in all HIV vaccine and microbicide efficacy trials combined. Advocates will need to weigh in now, as results from current efficacy trials may become available beginning as early as 2009. There is a role for prevention research advocates to seek answers to questions that can help to determine the next steps in the PrEP research program, to prepare for the trial results, and to ensure access to PrEP if proven effective.

In response to this challenge, the Prevention Research Advocacy Working Group (PRAWG) of HIV/AIDS Mobilization Project (CHAMP) recently formed a PrEP Committee. The PrEP Committee is composed of researchers and community advocates, including representatives from AIDS Vaccine Advocacy Coalition (AVAC), Global Campaign for Microbicides & Project Inform. It is focused on identifying questions that must be answered, fostering discussions in and beyond our communities about the opportunities and challenges of this potentially successful intervention, and preparing for advocacy efforts to ensure access to PrEP if proven effective.

The PrEP Committee has identified the following key areas of focus:

  • Research, including community acceptability
  • Prevention outreach, interventions, and services
  • Community education and engagement
  • Financing, access, and delivery

You are encouraged to join this national PrEP community education and advocacy campaign! It will take a massive effort to educate the community and advocate for ethical PrEP research and access to all who would benefit.

We invite people to join the PrEP Committee of the CHAMP Prevention Research Advocacy Working Group (PRAWG). To join the committee, please contact Josh Thomas, CHAMP Research Assistant, at josh@champnetwork.org, or call 401-427-2302 x 30.

Hey Josh, and the rest of

Hey Josh, and the rest of the PRAWG (now THAT is mellifluous!) - It would be great for one or more of you guys to come onto an IRMA teleconference - maybe October or November, to talk about this. As you know, IRMA is very supportive of, and interested in, PrEP research. Lets talk!

Jim Pickett
Director of Advocacy - AIDS Foundation of Chicago
Chair - International Rectal Microbicide Advocates (IRMA)

PrEP - Excellent Blog! Hi

PrEP - Excellent Blog! Hi Josh, thanks for updating us on the strides being undertaken toward establishing PrEP as a prevention tool in the battle against HIV transmission. I would hope that in the development of the advocacy agenda for '...preparing for advocacy efforts to ensure access to Prep..." that those preparations include a discussion on the delivery system responsible for ensuring that 'access'. I say this because of a male friend's recent (and scary) experience with a service provider pharmacy dropping the ball on a promised emergency overnight shipment of his HIV medications - (on vacation in another state, my friend was horrified to realize he forgot his HIV meds)- that constituted his missing a full week of those meds. If the health care delivery system is faulty, how are we going to 'ensure' access to PrEP for those individuals trying to access it??? Hope you are having a good time!

The comparison with PEP is

The comparison with PEP is right on the button. People have had to fight hard enough for the right to have ARVs prescribed to them AFTER they've had risky sex...how much more difficult is it going to be to convince healthcare workers, healthcare systems, and those who fund them that we should prescribe ARVs to people because they are CONTEMPLATING risky sex? This is going to be where the main advocacy struggle will take place once we have proof of efficacy, which I anticipate. The question of who gets PrEP and who decides who gets it will be paramount. By the way, both AVAC (Emily Bass) and IAS themselves (Yasmin Halima) have also now got workers specifically doing advocacy for PrEP. Gus

About

AIDS2008.com is an independent community resource sponsored by Community HIV/AIDS Mobilization Project (CHAMP) for the 2008 International AIDS Conference. read more »

Contact Us  |  Privacy Policy & Disclaimer